HomeZA71 • FRA
add
Larimar Therapeutics Inc
Previous close
€3.62
Day range
€3.40 - €3.40
Year range
€3.10 - €12.20
Market cap
229.07M USD
Avg Volume
35.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.26M | 76.65% |
Net income | -15.50M | -71.00% |
Net profit margin | — | — |
Earnings per share | -0.24 | -14.29% |
EBITDA | -18.19M | -77.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 203.71M | 113.10% |
Total assets | 219.02M | 110.69% |
Total liabilities | 20.62M | 83.46% |
Total equity | 198.40M | — |
Shares outstanding | 63.81M | — |
Price to book | 1.16 | — |
Return on assets | -20.02% | — |
Return on capital | -21.70% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -15.50M | -71.00% |
Cash from operations | -24.55M | -166.80% |
Cash from investing | 27.27M | 158.74% |
Cash from financing | 30.00K | 0.00% |
Net change in cash | 2.76M | 104.96% |
Free cash flow | -18.83M | -212.02% |
About
Founded
2005
Headquarters
Website
Employees
42
